Study Stopped
Recruitment too slow. Unrealistic to finish study with full recruitment.
Ultrasound-guided Venous Access for Pacemaker and Defibrillator Implants
TUFF
1 other identifier
interventional
58
1 country
1
Brief Summary
The study will include patients scheduled for transvenous pacemaker- or implantable defibrillator surgery, where venous access is necessary for lead implantation. A 1:1 randomization will be performed to either standard access (at the discretion of the surgeon) or ultrasound-guided using a wireless vascular transducer (Siemens Freestyle). Primary outcome is mean time to vascular access. In addition, success rate, complication rate and total procedure time will be measured.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Apr 2021
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2021
CompletedFirst Submitted
Initial submission to the registry
April 27, 2021
CompletedFirst Posted
Study publicly available on registry
April 30, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 27, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
February 27, 2025
CompletedMarch 4, 2025
April 1, 2024
3.9 years
April 27, 2021
February 27, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Mean time to complete venous access
Time from start of vascular access attempt to achieved access for the required number access points (ie number of leads)
Peroperatively
Secondary Outcomes (4)
Mean time to first venous access
Peroperatively
Successrate for full venous access
Peroperatively
Successrate for full venous access within 3 minutes
Peroperatively
Full venous access without any complication
Peroperatively within 24 hours
Study Arms (2)
Ultrasound guided venous access
EXPERIMENTALVascular access of the axillary vein will be performed using an ultrasound system (Siemens Acuson Freestyle) with a wireless vascular ultrasound probe (L8-3 or L13-5). One or more vascular punctures will be performed, as needed.
Standard of care
NO INTERVENTIONVascular access of the axillary or subclavian vein will be performed using anatomical landmarks, fluoroscopy and/or injection of X-ray contrast in the antecubital vein, at the choice of the implanter. One or more vascular punctures will be performed, as needed.
Interventions
Access of the axillary vein using ultrasound guidance.
Eligibility Criteria
You may qualify if:
- Planned pacemaker or implantable defibrillator surgery with at least one new transvenously placed lead.
You may not qualify if:
- Difficult vascular access known before surgery, where special access technique is planned or required.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Region Skanelead
Study Sites (1)
Skane University Hospital
Lund, Sweden
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 27, 2021
First Posted
April 30, 2021
Study Start
April 1, 2021
Primary Completion
February 27, 2025
Study Completion
February 27, 2025
Last Updated
March 4, 2025
Record last verified: 2024-04